An Emergency Medicine Broadsheet
·Phoenix·
Est. MMXXVI
Blue Fish Med · Today's Topic
Acute Flaccid Myelitis
AFM can progress rapidly from one limp limb to quadriparesis and respiratory failure. Early recognition, serial respiratory assessment, urgent imaging, and public-health coordination matter more than any unproven “magic” therapy.
Also known asAFM · polio-like syndrome · acute anterior myelitis
A 7-year-old boy arrives after breakfast with his mother, one arm hanging oddly at his side and a sleeve damp from spilled juice. Two days earlier he had fever and rhinorrhea; this morning he could not lift his right arm and now says his neck feels sore. He is alert, breathing comfortably, and has no rash, but the weakness is unmistakably flaccid. The next move has not yet been made.
— What’s your move? Read on.
Before you read
Which bedside finding determines whether the airway is already at risk?
What tests must be obtained before a potentially reversible cause is missed?
When to Think of It
Acute-onset flaccid limb weakness, often asymmetric, with reduced tone and reflexes; commonly follows a febrile viral prodrome. Facial weakness, dysphagia, dysarthria, neck weakness, urinary retention, or respiratory decline may occur. Sensory findings are usually absent or mild; a sensory level, bilateral leg-predominance, or early sphincter dysfunction should broaden the differential.
Sick or Not Sick
The key call is whether bulbar or respiratory motor involvement is developing. Obtain serial forced vital capacity and negative inspiratory force when feasible, but do not rely on numbers in a distressed child; assess cough, secretion handling, head lift, single-breath counting, work of breathing, and trend.
The First Fifteen Minutes
Any hypoxemia, hypoventilation, inability to handle secretions, or rapidly worsening bulbar weakness → prepare early for controlled intubation with pediatric airway expertise; do not wait for arrest. If paralysis is required, rocuronium 0.6–1.2 mg/kg IV (dose may require adjustment in neuromuscular disease; check institutional RSI protocol), because it provides predictable paralysis while avoiding succinylcholine-associated hyperkalemia concerns.
Shock or poor perfusion →isotonic crystalloid 10–20 mL/kg IV, reassessing after each bolus, because restoring preload supports spinal-cord and respiratory-muscle perfusion; use smaller boluses if myocarditis or renal failure is suspected.
Fever or pain →acetaminophen 15 mg/kg PO/IV every 6 hours, maximum 75 mg/kg/day or 4 g/day, because comfort improves examination and secretion management.
Place the child on continuous cardiorespiratory monitoring; obtain bedside glucose, CBC, electrolytes, CK, blood gas if respiratory concern, and urgent MRI brain and entire spine with contrast when possible.
Consult pediatric neurology and infectious disease early. Collect CSF and respiratory, stool, and serum specimens in coordination with public health; do not delay stabilization for specimen collection.
Definitive Care & Disposition
Admit any suspected AFM to a pediatric center with PICU and neurology capability; PICU if bulbar, neck, diaphragmatic, or rapidly progressive weakness. MRI should look for gray-matter–predominant spinal cord lesions. Lumbar puncture typically shows lymphocytic pleocytosis and elevated protein; send infectious and inflammatory studies guided by neurology/ID. There is no proven disease-specific antiviral or immunotherapy. If inflammatory myelitis remains likely, neurology may give methylprednisolone 30 mg/kg IV daily, maximum 1 g/day, for 3–5 days; IVIG or plasma exchange may be considered case-by-case, but evidence is limited and dosing should be confirmed with a specialist/reference. Begin early rehabilitation, pressure-injury prevention, pulmonary toilet, nutrition assessment, and mandatory public-health reporting.
How This One Kills
The lethal error is treating an initially comfortable child as neurologically stable while diaphragmatic or bulbar weakness advances; respiratory failure may appear abruptly with little warning from oxygen saturation until late.
The Differential — What Else Looks Like This
Guillain-Barre syndrome — usually symmetric ascending weakness with areflexia and less striking gray-matter spinal MRI changes; confusing them can delay appropriate monitoring and CSF/EMG interpretation.
Transverse myelitis — sensory level, bilateral weakness, sphincter dysfunction, and upper-motor-neuron evolution favor it; mislabeling it AFM can delay urgent inflammatory-spinal-cord treatment.
Spinal cord compression — severe back/neck pain, trauma, malignancy, or compressive MRI lesion; delay risks irreversible paralysis.
Botulism — descending symmetric paralysis with fixed/dilated pupils or autonomic symptoms; missing it delays antitoxin and exposure investigation.
The Second-Day Story
Older children may present with isolated hand weakness, facial asymmetry, dysphagia, or unexplained neck fatigue rather than obvious quadriparesis. Fever may have resolved, the child may deny sensory symptoms, and early reflexes can be variable. A careful comparison of tone, reflexes, cranial nerves, cough, and single-breath performance—followed by serial examinations—often reveals progression that the first snapshot misses.
Back to Our Patient
Back to the 7-year-old boy with the damp sleeve: acute asymmetric flaccid weakness after a viral prodrome, minimal sensory symptoms, and reduced tone/reflexes make AFM a leading concern, but GBS, transverse myelitis, and compression remain active alternatives. His cough is weak and he cannot sustain a 10-second breath count, so he is high risk despite normal oxygen saturation; he receives monitoring, serial respiratory measurements, glucose and laboratory testing, urgent brain/spine MRI, and neurology/ID consultation, with early PICU airway planning. CSF and public-health specimens are obtained after stabilization. He is admitted to the PICU for evolving bulbar/respiratory risk and diagnostic confirmation.
Patient Presentation to Attending
How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling
“This is a previously healthy 7-year-old boy with two days of febrile upper-respiratory symptoms who developed abrupt right-arm flaccid weakness this morning, now with neck fatigue. He is alert and afebrile, has asymmetric hypotonia and reduced right-arm reflexes, no clear sensory level, no trauma or back pain, and no altered mental status, but his cough is weak and he cannot sustain a 10-second breath count. Oxygen saturation is normal, glucose is normal, and labs are pending; GBS, transverse myelitis, compression, and botulism remain in the differential, with AFM currently most concerning. I’m placing him on continuous monitoring, obtaining serial respiratory measurements, urgent MRI of the brain and entire spine, and consulting pediatric neurology, infectious disease, and PICU now. If bulbar or respiratory function worsens, we will proceed with controlled airway management rather than wait for desaturation.”
Study Directive
Draw a localization map contrasting anterior horn cell, peripheral nerve, spinal cord tract, neuromuscular junction, and muscle disease.
Practice documenting serial cough strength, neck flexion, secretion handling, FVC, and NIF in a simulated child with progressive weakness.
Review CDC AFM case definitions and create a specimen-collection checklist with pediatric neurology/ID.
Compare AFM, GBS, transverse myelitis, botulism, and cord compression in a five-column differential grid.
Verify pediatric RSI and steroid dosing in your institutional protocol or Lexicomp.
A comprehensive clinical reference for recognizing the characteristic acute asymmetric weakness, obtaining appropriate spinal MRI and CSF studies, excluding mimics, and prioritizing respiratory monitoring and early multidisciplinary care.
MG is a fluctuating disorder that can look benign until bulbar and respiratory muscles fail. The emergency physician must recognize the pattern, identify...
A 34-year-old woman sits beneath the fluorescent lights, holding her chin with one hand as the afternoon wears on. Her eyelids droop after she reads a message, and her voice becomes nasal while describing a normal breakfast conversation. She has no numbness, pain, or altered sensation, but her smile fades after repeated effort. The question is whether this is fatigue—or a dangerous failure of neuromuscular transmission.
Before You Read
Which examination maneuver best demonstrates fatigable weakness?
How do you distinguish ocular disease from impending generalized crisis?
Which common medications can turn a stable patient into an airway emergency?
Why It Matters
MG is a fluctuating disorder that can look benign until bulbar and respiratory muscles fail. The emergency physician must recognize the pattern, identify precipitants, and avoid iatrogenic worsening.
When to Think of It
Fluctuating, fatigable weakness that improves with rest: ptosis, diplopia, dysarthria, dysphagia, facial weakness, neck flexion weakness, and proximal limb weakness. Pupils and sensation are normal. Test sustained upgaze, repeated counting aloud, forced eyelid closure, neck flexion, and proximal strength before and after repetition.
Sick or Not Sick
The critical call is isolated ocular disease versus bulbar/respiratory involvement. Ask about choking, nasal speech, weak cough, inability to count in one breath, orthopnea, and rapid progression; measure FVC/NIF when possible, but clinical trajectory overrides reassuring single values.
The First Fifteen Minutes
Bulbar weakness, weak cough, inability to handle secretions, hypercapnia, or rapidly declining respiratory mechanics → move to a monitored resuscitation area and call anesthesia/ICU early. If intubation is needed, use etomidate 0.3 mg/kg IV for induction and rocuronium 0.6 mg/kg IV for paralysis; MG patients are unusually sensitive to nondepolarizing blockers, so confirm the dose with the airway team and local protocol.
Secretions threatening the airway → suction, position upright, and use noninvasive ventilation only if the patient is alert, protecting the airway, and clearing secretions; NIV must not delay intubation.
Stable known MG with missed doses and no crisis → discuss resuming pyridostigmine 60 mg PO every 6 hours with neurology; it improves acetylcholine availability but does not rescue impending respiratory failure and may increase secretions.
Obtain ECG, glucose, electrolytes, blood gas if respiratory concern, chest imaging when infection/aspiration is suspected, and targeted infectious evaluation. Avoid sedatives unless necessary.
Definitive Care & Disposition
Ocular-only, stable patients require neurology follow-up and evaluation for precipitating medications, infection, thymoma, and autoimmune disease. Any bulbar or respiratory involvement warrants ICU-level monitoring. Confirm diagnosis with neurology using AChR and MuSK antibodies, electrodiagnostic testing, and chest imaging for thymoma. Treat triggers such as pneumonia or aspiration. Avoid or use caution with aminoglycosides, fluoroquinolones, macrolides, magnesium, beta-blockers, and sedatives; never withhold a necessary antibiotic without discussing alternatives.
How This One Kills
The classic failure is reassuring yourself with a normal oxygen saturation while progressive diaphragmatic weakness causes hypercapnic arrest; pulse oximetry can remain normal until ventilation is already failing.
The Atypical Presentation
Older adults may present with dysarthria, dysphagia, head drop, or unexplained aspiration without obvious ptosis. Patients often describe “fatigue,” but the discriminating feature is task-dependent weakness that worsens with repetition and improves with rest. A normal limb examination does not exclude isolated bulbar MG; listen to sustained speech and assess cough, palate movement, and secretion control.
Back to Our Patient
Back to the 34-year-old woman: fatigable ptosis, nasal speech after sustained talking, normal sensation, and no fixed focal deficit point toward MG rather than stroke or primary muscle disease. She is asked to count and cough; because her cough remains strong, she handles secretions, and respiratory mechanics are stable, she is not in crisis. Neurology recommends resuming her missed pyridostigmine, reviews medication triggers, evaluates for infection and thymoma, and arranges urgent follow-up. She is discharged only after a reliable observation period, return precautions for dysphagia, dyspnea, and weak cough, and a clear neurology plan.
Patient Presentation to Attending
“This is a 34-year-old woman with several weeks of intermittent diplopia and ptosis, now worse after prolonged reading and speaking. Examination shows fatigable bilateral ptosis and dysarthric, nasal speech after counting, but normal pupils, sensation, mental status, and no abrupt focal deficit. She has a strong cough, is managing secretions, has no orthopnea, and her respiratory mechanics are stable. The pattern is most consistent with ocular-predominant myasthenia gravis without current crisis. I’m placing her on monitoring, screening for infection and medication precipitants, discussing pyridostigmine resumption with neurology, and will admit if bulbar or respiratory function worsens.”
Study Directive
Perform and document a fatigability examination on three patients or in simulation.
Memorize the clinical distinction between ocular MG, generalized MG, and crisis.
Build a one-page “MG medication danger list” and verify it against your hospital formulary.
Practice a 30-second airway-risk presentation using cough, counting, bulbar symptoms, FVC/NIF, and trajectory.
Review AChR versus MuSK disease and thymoma evaluation with a neurology resource.
Key Medications
Pyridostigmine: 60 mg PO every 6 hours for a stable patient under neurology guidance; dosing varies by formulation and patient response.
Etomidate for RSI: 0.3 mg/kg IV.
Rocuronium for RSI: 0.6 mg/kg IV, with heightened sensitivity in MG; verify institutional protocol.
Avoid routine magnesium, aminoglycosides, fluoroquinolones, macrolides, and beta-blockers when alternatives exist.
Pediatric MG dosing is specialist-directed and weight-based; verify with Lexicomp or institutional protocol.
High-Yield Pearls
Dysarthria and dysphagia may precede obvious limb weakness; listen to the patient speak continuously rather than relying on a brief phrase.
A normal oxygen saturation is not a ventilation assessment; trend cough, secretion control, blood gas, and respiratory mechanics.
Magnesium and several antibiotic classes can worsen transmission; medication reconciliation is an active emergency intervention.
The Mimics
Botulism — fixed/dilated pupils, autonomic symptoms, and descending paralysis; confusing it delays antitoxin and public-health action.
Lambert-Eaton syndrome — proximal leg weakness with autonomic symptoms and facilitation after exercise; MG-directed assumptions can miss occult malignancy.
Brainstem stroke — abrupt fixed deficit rather than fatigability; mislabeling stroke as MG delays reperfusion evaluation.
Multiple sclerosis — sensory, optic, or upper-motor-neuron findings; attributing objective sensory signs to MG delays CNS imaging.
Board Question
Which bedside finding most strongly supports myasthenia gravis?
ASensory loss in a stocking distribution
BWeakness that worsens with repeated effort and improves with rest
CHyperreflexia with Babinski signs
DFixed unilateral pupillary dilation
Reveal answer
Correct: B
Fatigability with preserved sensation and pupils is characteristic of MG. The other findings suggest peripheral neuropathy, central corticospinal disease, or a pupillary/brainstem process.
Synthesizes the evidence for IVIG in myasthenic exacerbation and crisis, helping emergency clinicians weigh this rapid immunomodulatory therapy against plasma exchange.
Myasthenic crisis is ventilatory and bulbar failure from inadequate neuromuscular transmission, often triggered by infection, surgery, medication changes,...
A 68-year-old man is leaning forward on the stretcher, his reading glasses abandoned beside a cup of untouched coffee. His wife says he has been choking on water since yesterday and now pauses between every few words. He is awake and frightened, with a weak cough but a normal oxygen saturation. The airway team has not yet been called.
Before You Read
When should a patient with MG be intubated before overt hypoxemia?
How do myasthenic and cholinergic crises differ at the bedside?
Which rescue therapies work quickly enough to matter in the ED?
Why It Matters
Myasthenic crisis is ventilatory and bulbar failure from inadequate neuromuscular transmission, often triggered by infection, surgery, medication changes, or aspiration. Delay in airway control and inappropriate medication selection can convert a treatable crisis into arrest.
When to Think of It
Progressive dysphagia, dysarthria, weak cough, pooling secretions, neck flexion weakness, orthopnea, tachypnea, paradoxical breathing, or falling FVC/NIF in a patient with MG. Infection, recent surgery, missed pyridostigmine, new antibiotics, and steroid initiation are common precipitants.
Sick or Not Sick
The decisive call is whether the patient can protect the airway and sustain ventilation. Bulbar dysfunction, inability to clear secretions, rapidly worsening weakness, hypercapnia, or exhaustion favors early intubation; do not wait for cyanosis.
The First Fifteen Minutes
Inability to protect the airway, worsening hypercapnia, exhaustion, or rapidly declining respiratory mechanics → call anesthesia/ICU and perform controlled intubation. Use etomidate 0.3 mg/kg IV and, if paralysis is necessary, rocuronium 0.6 mg/kg IV; MG patients may have prolonged sensitivity, so use the minimum effective dose and confirm local protocol.
Secretions with preserved airway protection → suction and upright positioning; glycopyrrolate 0.1–0.2 mg IV, repeat every 4 hours as needed, may reduce troublesome secretions while producing less CNS effect, but it does not treat the crisis.
Strong suspicion for myasthenic crisis after neurology consultation → start IVIG 0.4 g/kg/day IV for 5 days or plasma exchange, typically 5 exchanges over 7–10 days; dosing and access decisions vary, so verify with neurology and institutional protocol.
Do not reflexively escalate pyridostigmine during respiratory failure; excess cholinergic effect can increase secretions and complicate airway management. Hold or adjust it with neurology if intubated.
Definitive Care & Disposition
All crises require ICU admission. Treat infection, aspiration, electrolyte abnormalities, and medication triggers. IVIG and plasma exchange have similar clinical roles; plasma exchange may act faster but requires vascular access and carries hemodynamic/infectious risks. Steroids are often started after rescue therapy, because early high-dose corticosteroids can transiently worsen weakness; a common specialist regimen is prednisone 10–20 mg PO daily with gradual escalation, but confirm the plan. After stabilization, evaluate thymoma, optimize long-term immunotherapy, and involve respiratory therapy, speech/swallow, and nutrition.
How This One Kills
The dangerous mistake is treating increasing secretions and weakness with repeated pyridostigmine while assuming the patient is undertreated; cholinergic excess can worsen bronchial secretions, bradycardia, fasciculations, and respiratory failure.
The Atypical Presentation
A patient may present with aspiration pneumonia, unexplained hypercapnia, or inability to lie flat rather than reporting “weakness.” Prior intubation, sedatives, obesity, and chronic lung disease obscure the neuromuscular signal. Follow the trajectory of speech, cough, secretion burden, neck flexion, and blood gas rather than waiting for a dramatic fall in oxygen saturation.
Back to Our Patient
Back to the 68-year-old man: new dysphagia, weak cough, interrupted speech, and secretion difficulty identify impending myasthenic crisis despite normal oxygen saturation. He is moved to resuscitation, placed upright with suction ready, and anesthesia/ICU are called for controlled intubation before fatigue becomes arrest; respiratory mechanics and blood gas are trended. Neurology starts IVIG at 0.4 g/kg/day for five days, reviews recent medications and infection triggers, and holds or adjusts pyridostigmine during airway management. He is admitted to the ICU for ventilatory support, rescue therapy, aspiration evaluation, and later long-term MG optimization.
Patient Presentation to Attending
“This is a 68-year-old man with known MG who has had one day of progressive dysphagia, nasal dysarthria, and weak cough, now pausing between words. He is awake but pooling secretions and cannot clear them effectively; oxygen saturation is normal, but he has worsening neck flexion weakness and hypercapnia on blood gas. There is no miosis, diarrhea, diaphoresis, fever, or focal sensory deficit to suggest cholinergic crisis, sepsis, or stroke. This is impending myasthenic crisis with a threatened airway. I’m moving him to resuscitation, calling anesthesia and ICU for controlled intubation, providing suction and monitoring, and consulting neurology to begin IVIG or plasma exchange while we investigate infection, aspiration, and medication triggers.”
Study Directive
Memorize an airway trigger list for MG: secretion failure, weak cough, hypercapnia, exhaustion, and rapidly worsening mechanics.
Compare IVIG and plasma exchange in terms of onset, contraindications, access, and complications.
Rehearse an RSI plan for MG, including reduced neuromuscular-blocker sensitivity assumptions and post-intubation sedation.
Review five medication classes that worsen MG and identify safer alternatives in your ED.
Work through one case each of myasthenic crisis and cholinergic crisis without looking at the answer.
Key Medications
IVIG: 0.4 g/kg/day IV for 5 days; confirm product-specific dosing and renal/thrombotic precautions.
Plasma exchange: commonly 5 exchanges over 7–10 days; prescription is weight- and center-dependent—verify with neurology/apheresis.
Etomidate: 0.3 mg/kg IV for RSI.
Rocuronium: 0.6 mg/kg IV for RSI; sensitivity and duration may be increased in MG.
Glycopyrrolate: 0.1–0.2 mg IV q4h PRN for secretions; confirm local protocol.
Prednisone: often 10–20 mg PO daily with gradual escalation, but regimen varies substantially; check Lexicomp, UpToDate, or institutional protocol.
Pediatric crisis management is specialist-directed; use pediatric neuromuscular and airway protocols.
High-Yield Pearls
Hypercapnia is late evidence of respiratory-muscle failure; a normal SpO₂ cannot rule out crisis.
Plasma exchange is often favored when a very rapid response is needed, whereas IVIG is easier when access or hemodynamic stability is problematic.
Cholinergic crisis is defined by autonomic excess and secretions—not simply “very weak MG.”
The Mimics
Cholinergic crisis — muscarinic/autonomic signs such as miosis, diaphoresis, diarrhea, bradycardia, and bronchorrhea; confusing it with myasthenic crisis worsens secretions and airway risk.
Sepsis with respiratory fatigue — fever, hypotension, lactate elevation, and nonfluctuating weakness; attributing all decline to MG delays source control.
Critical illness polyneuropathy — develops during prolonged ICU illness rather than abrupt fatigable bulbar decline; the wrong attribution can lead to inappropriate escalation of cholinesterase therapy.
Board Question
A patient with MG has progressive dysphagia, weak cough, and rising PaCO₂ but normal oxygen saturation. What is the best next step?
ADischarge after a dose of pyridostigmine
BWait for oxygen saturation to fall below 90%
CEarly controlled endotracheal intubation and ICU admission
DGive magnesium for neuromuscular support
Reveal answer
Correct: C
Hypercapnia, bulbar dysfunction, and inability to clear secretions indicate ventilatory and airway-protection failure; oxygen saturation may remain normal. Magnesium can worsen neuromuscular transmission.
Defines the evidence for IV immunoglobulin in worsening myasthenia gravis, informing its use as rapid immunomodulatory therapy during severe exacerbation or crisis.
Shows that FcRn blockade with nipocalimab can improve generalized myasthenia gravis, a useful emerging therapy to recognize when evaluating patients with refractory or treatment-complicated disease.
Posterior circulation ischemia can present as dizziness, vomiting, diplopia, dysarthria, or ataxia without obvious limb weakness. Missing basilar or...
A 59-year-old man grips the rail as the hallway tilts beneath him, his emesis basin smelling sharply of coffee and bile. He says he “just got dizzy” when he stood up, but he cannot walk without falling to the left and his wife noticed that his voice sounds thick. The triage note says “vertigo,” while the clock on the wall marks 42 minutes since he was last normal. The decision to activate the stroke pathway has not yet been made.
Before You Read
Which examination findings make isolated peripheral vertigo unsafe to assume?
What imaging is required when posterior stroke is suspected?
When are thrombolysis and thrombectomy still options?
Why It Matters
Posterior circulation ischemia can present as dizziness, vomiting, diplopia, dysarthria, or ataxia without obvious limb weakness. Missing basilar or cerebellar ischemia can mean preventable brainstem infarction, coma, and death.
When to Think of It
Sudden persistent vertigo or imbalance with inability to walk, limb or truncal ataxia, direction-changing or vertical nystagmus, skew deviation, diplopia, dysarthria, dysphagia, unilateral hearing loss, crossed cranial-nerve findings, limb weakness, headache, or new occipital pain. HINTS is useful only in continuous acute vestibular syndrome with spontaneous nystagmus and an examiner trained in the full battery; it is not a general dizziness screen.
Sick or Not Sick
The key call is central versus peripheral acute vestibular syndrome—and whether there is basilar large-vessel occlusion. A patient who cannot stand or walk, has a central ocular-motor pattern, new cranial-nerve deficit, or persistent disabling symptoms needs emergent stroke imaging and neurologic consultation.
The First Fifteen Minutes
Any suspected stroke → establish last-known-well, glucose, NIHSS plus focused posterior examination, two IVs, cardiac monitoring, and emergent noncontrast head CT plus CTA head/neck; CT may be normal, while CTA can reveal vertebrobasilar occlusion.
Glucose <60 mg/dL with neurologic symptoms →dextrose 25 g IV (50 mL of D50) or institutional equivalent, because hypoglycemia can mimic stroke; recheck glucose.
Disabling deficit within 4.5 hours, hemorrhage excluded, and eligible →tenecteplase 0.25 mg/kg IV once, maximum 25 mg (or alteplase 0.9 mg/kg IV, maximum 90 mg: 10% bolus and remainder over 60 minutes), because fibrinolysis can reopen an occluded vessel. Confirm current institutional stroke protocol and contraindications.
BP above 185/110 before thrombolysis →labetalol 10–20 mg IV over 1–2 minutes, repeat once, or nicardipine 5 mg/h IV, titrating by 2.5 mg/h every 5–15 minutes, because controlled BP reduces hemorrhagic transformation risk. If no thrombolysis, avoid routine BP reduction unless extreme or another emergency exists.
No thrombolysis and hemorrhage excluded →aspirin 325 mg PO/NG once; do not give aspirin within 24 hours after thrombolysis until follow-up imaging excludes hemorrhage.
Protect the airway for declining consciousness, vomiting with impaired protection, or bulbar failure; check temperature and swallow safety before oral intake.
Definitive Care & Disposition
MRI with diffusion-weighted imaging is more sensitive for posterior infarction but must not delay reperfusion therapy or thrombectomy evaluation. Basilar artery occlusion or selected vertebral/posterior large-vessel occlusion may require endovascular thrombectomy, often up to 24 hours in appropriate imaging-selected patients. Admit suspected central vertigo or stroke to a stroke-capable center; ICU-level care is needed for brainstem compromise, hydrocephalus, declining consciousness, or airway risk. Cerebellar infarction with swelling may require neurosurgical decompression or external ventricular drainage. A negative early CT or MRI does not override a highly concerning clinical syndrome.
How This One Kills
The catastrophic miss is labeling inability to walk, dysarthria, or direction-changing nystagmus as “benign vertigo,” discharging the patient while a basilar occlusion progresses to locked-in syndrome or respiratory arrest.
The Atypical Presentation
Older adults may report only nausea, vague imbalance, headache, or “walking funny,” and patients with baseline neuropathy may not describe ataxia clearly. A small medullary or cerebellar infarct can have a low NIHSS because the scale underweights posterior deficits. Ask specifically about diplopia, swallowing, voice change, hearing, severe gait instability, and abrupt onset; observe gait and eye movements rather than accepting the label “dizziness.”
Back to Our Patient
Back to the 59-year-old man: sudden persistent vertigo, inability to walk, falling to the left, and dysarthria are central warning signs, not a routine “dizzy” complaint. His glucose is normal, CT shows no hemorrhage, and CTA reveals a basilar artery occlusion; because he is within the treatment window with a disabling deficit and no contraindication, the stroke team gives tenecteplase and transfers him urgently for thrombectomy evaluation. BP is managed to the thrombolysis threshold, he remains NPO with airway monitoring, and he is admitted to the neuro-ICU for reperfusion care and surveillance for brainstem edema and respiratory decline.
Patient Presentation to Attending
“This is a 59-year-old man with abrupt persistent vertigo beginning 42 minutes ago, associated with vomiting, new dysarthria, and inability to walk without falling left. He has direction-changing nystagmus and truncal ataxia, with no positional trigger, no prior similar episodes, and a normal glucose; the symptoms are disabling and concerning for posterior circulation stroke. Noncontrast CT shows no hemorrhage, and CTA demonstrates basilar artery occlusion. He is within the reperfusion window, so I’m activating the stroke and endovascular teams, giving protocol-directed tenecteplase after confirming contraindications, controlling BP if needed, and transferring him to the neuro-ICU with immediate thrombectomy evaluation.”
Study Directive
Perform and document HINTS-plus only in the correct acute vestibular syndrome population, ideally with expert feedback.
Memorize thrombolysis BP thresholds, tenecteplase dosing, and the 24-hour post-lysis aspirin rule.
Review three CTA examples of vertebrobasilar occlusion and identify which patients require thrombectomy consultation.
Practice a posterior-stroke neurologic examination focused on gait, nystagmus, skew, dysarthria, dysphagia, and cranial nerves.
Create a “dizziness discharge checklist” requiring a clear episodic versus continuous history, gait assessment, ocular examination, glucose, and return precautions.
Key Medications
Tenecteplase: 0.25 mg/kg IV once, maximum 25 mg; verify current stroke protocol and eligibility.
Alteplase: 0.9 mg/kg IV, maximum 90 mg; 10% as bolus, remainder over 60 minutes; confirm contraindications and institutional protocol.
Labetalol: 10–20 mg IV over 1–2 minutes, may repeat once; verify local BP protocol.
Nicardipine: 5 mg/h IV infusion, titrate by 2.5 mg/h every 5–15 minutes, maximum commonly 15 mg/h; check institutional protocol.
Aspirin: 325 mg PO/NG once after hemorrhage is excluded and when thrombolysis was not given.
Dextrose for symptomatic hypoglycemia: 25 g IV, with repeat glucose measurement; concentration and peripheral-line policy vary.
A low NIHSS does not make posterior stroke low risk; gait, ocular motor findings, dysphagia, and cranial nerves may carry the diagnosis.
HINTS is not validated for brief episodic dizziness or for untrained examiners; misuse can falsely reassure.
Early CT is primarily for hemorrhage and gross lesions; persistent disabling symptoms with a negative CT still require vascular imaging and specialist assessment.
The Mimics
Vestibular neuritis — unidirectional horizontal nystagmus, abnormal head-impulse test, and preserved gait relative to symptoms; confusing it with stroke risks missed posterior ischemia.
Benign paroxysmal positional vertigo — brief, position-triggered episodes with characteristic latency and fatigability; persistent spontaneous symptoms should not be dismissed as BPPV.
Hypoglycemia — low bedside glucose with rapid improvement after correction; failure to check glucose delays simple reversal and may trigger inappropriate thrombolysis.
Vestibular migraine — recurrent episodes with migraine history and no fixed focal deficits; anchoring on it can miss a first posterior stroke.
Board Question
Which patient with acute vestibular syndrome most strongly requires emergent evaluation for posterior circulation stroke?
ABrief vertigo triggered by rolling in bed with fatigable torsional nystagmus
BContinuous vertigo with unidirectional nystagmus, normal gait, and an abnormal head-impulse test
CContinuous vertigo with inability to stand, direction-changing nystagmus, and new dysarthria
DRecurrent vertigo identical to prior episodes with normal neurologic examination
Reveal answer
Correct: C
Inability to stand, direction-changing nystagmus, and dysarthria are central features requiring stroke evaluation. BPPV and vestibular neuritis have characteristic peripheral patterns, although recurrent symptoms should still be reassessed when atypical.
A practical reference for recognizing often subtle posterior circulation stroke presentations, choosing appropriate vascular imaging, and initiating time-sensitive reperfusion management.
A quick test of recall from prior editions. Commit to an answer before you check.
From yesterday's edition
A 71-year-old man with a known left bundle branch block presents with chest pain. The old rule of 'new LBBB equals STEMI' has been retired, but ischemia in LBBB still has to be diagnosed somehow. What’s the diagnosis, and the first move?
Check your answer
Sgarbossa Criteria. Apply modified Sgarbossa to any LBBB or ventricular paced rhythm with concerning chest pain. A positive score warrants STEMI activation. A negative score does not rule out MI — admit, serial troponin, and serial ECGs as the symptoms and risk profile dictate.
From the August 16 edition
Today, three days ago: Dextrose. What’s the adult ED dose, and the contraindication you’d most regret missing?
Check your answer
D50W 25 g IV (50 mL of 50%) for severe adult hypoglycemia; D10W 100–250 mL IV is a vein-friendlier alternative. Follow with food or infusion if long-acting insulin/sulfonylurea risk. No absolute contraindication in severe hypoglycemia.
From the August 9 edition
A 34-year-old with a T4 spinal cord injury has BP 78/42, HR 48, warm extremities, and no external bleeding. After a negative FAST and chest/pelvis evaluation, which is the best next treatment?
A2 g IV calcium chloride
BNorepinephrine infusion
CHigh-dose methylprednisolone
DFurosemide IV
Reveal answer
Correct · B
Norepinephrine infusion. Neurogenic shock causes loss of sympathetic vascular tone and bradycardia; norepinephrine supports vascular resistance and spinal cord perfusion. Steroids are not routine therapy, and hemorrhage must be excluded before attributing shock to neurogenic physiology.
Journal Watch
From the FOAMed wire
No new items in the last week. The wire resumes when sources update.
In this episode, Sam Ashoo, MD and Dr. T.R. Eckler, MD discuss the July 2026 Emergency Medicine Practice article, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management in the Emergency Department . 0:17 – Intro & sponsor promo 1:09 – Episode introduction 4:03 – Definitions: SJS vs. TEN vs. "overlap" by body surface area 6:12 –...
Facial trauma is common in emergency medicine, but the biggest pitfalls are often not the fractures themselves—they're the threatened airway, vision-threatening ocular injuries, missed septal hematomas, and subtle...
UMEM Pearl
Matched to today’s topics
A clinical pearl from the University of Maryland EM group’s Educational Pearls, tied to today’s differential.
If “no big deal” proves to be posterior circulation ischemia, occlusion anatomy still governs treatment: negative medium/distal-vessel thrombectomy data should not be extrapolated to large-vessel basilar occlusion.
Bottom Line: In patients with acute ischemic stroke due to medium or distal vessel occlusion, mechanical thrombectomy did not improve functional outcomes at 3 months and was associated with an increased risk of symptomatic intracranial hemorrhage.
Critical Care Corner
Matched to today’s topics
A critical-care reference from LITFL’s Critical Care Compendium, tied to today’s differential.
Myasthenia gravis becomes an ICU problem when bulbar weakness and declining respiratory mechanics signal crisis, demanding early ventilatory planning rather than reliance on pulse oximetry.
Myasthenia Gravis: autoimmune disruption of post-synaptic acetylcholine receptors at NMJ; up to 80% of functional receptors loss; typically young woman; may have thymus hyperplasia; prevalence = 14.2 cases per 100,000
Pharmacology Corner
Two drugs for the shift
One antimicrobial and one other ED workhorse — selected daily, with sources and last-reviewed dates so every dose is cross-checkable.
Antimicrobial of the Day
Piperacillin-Tazobactam
Beta-lactam / beta-lactamase inhibitor
Indication
Broad-spectrum coverage for nosocomial pneumonia, intra-abdominal infection, complicated UTI, neutropenic fever, and undifferentiated sepsis with Pseudomonas risk.
What’s your dose? — reveal dosing & cautions
ED Dose
3.375 g IV q6h (extended infusion 4 h preferred for serious infection); 4.5 g IV q6h for severe pseudomonal infection or critical illness.
Renal Adjustment
CrCl 20–40: 3.375 g q8h. CrCl < 20: 2.25 g q8h. Hemodialysis: 2.25 g q8h plus 0.75 g after each session.
Contraindications
Penicillin or beta-lactam anaphylaxis history.
Interactions
Vancomycin (increased AKI risk per recent observational data); methotrexate (decreased clearance); probenecid (prolongs half-life).
Monitoring
Renal function, electrolytes (sodium load), platelets with prolonged courses.
ED Pearl
Order the loading dose immediately on sepsis recognition — every hour of antibiotic delay in septic shock raises mortality. Use extended-infusion protocols if your pharmacy supports them.
Acute agitation, nausea/vomiting, migraine adjunct, cannabinoid hyperemesis, and vertigo-associated nausea in selected patients.
What’s your dose? — reveal dosing & cautions
ED Dose
Nausea/migraine: 0.625–2.5 mg IV/IM. Agitation: 5–10 mg IM/IV depending on severity and local protocol.
Renal Adjustment
No renal adjustment; caution in hepatic impairment.
Contraindications
Known QT prolongation/TdP risk when significant, Parkinson disease/Lewy body dementia caution, severe CNS depression.
Interactions
Other QT-prolonging drugs, CNS depressants, dopamine agonists antagonized.
Monitoring
Sedation, BP, extrapyramidal symptoms, QTc in high-risk patients or higher/repeated doses.
ED Pearl
Droperidol is one of the most useful ED symptom-control drugs; respect QT risk, but do not let the black-box warning erase good medicine in appropriately selected patients.
For educational use only. Verify dosing against the FDA label and your institution’s pharmacy resources before administering.
ECG of the Day
Pulmonary
Pulmonary Embolism / RV Strain
ECG cannot rule out PE, but acute right-heart strain patterns can identify a sicker PE phenotype.
The Tracing
A 51-year-old woman with sudden dyspnea, pleuritic chest pain, and syncope has an ECG showing sinus tachycardia, a new right bundle branch block, right-axis deviation, and deep T-wave inversions in V1 through V4 and lead III. The classic S1Q3T3 pattern is present but subtle. Bedside echo shows RV dilation.
Sinus tachycardia is the most common ECG abnormality
Right ventricular strain pattern: T-wave inversions in V1–V4 and inferior leads, especially lead III
Right-axis deviation, right bundle branch block, or incomplete RBBB may occur
S1Q3T3 can be present but is neither sensitive nor specific
Severe PE can produce atrial arrhythmias, ST elevation in aVR, or anterior ischemia mimics from RV pressure overload
Pearls
Anterior T-wave inversions in PE often reflect RV strain, not LAD ischemia; the clinical context and echo help separate them.
ECG is a risk-stratification clue, not a rule-out tool. A normal ECG never excludes PE.
Syncope plus RV strain on ECG should push you toward higher-risk PE thinking while definitive imaging and resuscitation proceed.
Pitfalls
Do not wait for S1Q3T3. It is memorable, not reliable.
Do not dismiss anterior T-wave inversions as anxiety or nonspecific changes in a hypoxic tachycardic patient.
PE can coexist with ACS risk factors; avoid premature closure when the story or troponin is mixed.
At the Bedside
Use the ECG to support concern for RV strain and severity while pursuing PE workup. If unstable, activate local massive PE pathway, obtain bedside echo when available, start anticoagulation if not contraindicated, and consider thrombolysis or advanced therapy per protocol.
For educational use only. Verify ECG interpretation against the LITFL entry and your institution’s practice before clinical decision-making.
Case of the Day
From the lead · Acute Flaccid Myelitis
Self-Examination
Test Your Understanding
A 9-year-old develops asymmetric flaccid arm weakness after a viral illness. MRI shows a longitudinal spinal cord lesion with prominent anterior horn gray-matter involvement. Which additional finding most strongly supports acute flaccid myelitis over transverse myelitis?
AA clear truncal sensory level
BEarly urinary retention
CMarked asymmetric weakness with minimal sensory symptoms
DBilateral leg spasticity
Reveal answer
Correct answer · C
AFM classically causes acute asymmetric flaccid weakness with anterior horn involvement and little sensory disturbance. A sensory level, sphincter dysfunction, and evolving spasticity favor transverse myelitis.
Study Pace4 topics today; Issue 36 of 94 — Neurology (Week 19)Deadline · June 1, 2026